Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three drugs—bupivacaine, epinephrine (adrenaline), and fentanyl—commonly used in regional anesthesia, particularly for epidural or spinal analgesia during labor, cesarean section, and postoperative pain management. - **Bupivacaine** is an amide-type local anesthetic that blocks voltage-gated sodium channels on neuronal membranes, inhibiting nerve impulse conduction and providing local or regional anesthesia[6][10]. - **Epinephrine** acts as a vasoconstrictor by stimulating alpha-adrenergic receptors. When added to local anesthetics like bupivacaine (and opioids like fentanyl), it reduces systemic absorption of the drugs at the injection site by constricting blood vessels. This prolongs the duration of action and enhances analgesic effects[4][5][7]. - **Fentanyl** is a potent synthetic opioid agonist at the mu-opioid receptor. It provides additional analgesia through central nervous system action[9]. The combination leverages synergistic effects between these agents to improve pain relief quality and duration while potentially reducing required doses of each component[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bupivacaine + epinephrine + fentanyl.